Page last updated: 2024-08-21

podophyllotoxin and Adenocarcinoma, Alveolar

podophyllotoxin has been researched along with Adenocarcinoma, Alveolar in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Falkson, G; Falkson, HC; van den Bergh, JA; van der Merwe, AM; van Dyk, JJ; van Eden, EB1

Other Studies

1 other study(ies) available for podophyllotoxin and Adenocarcinoma, Alveolar

ArticleYear
A clinical trial of the oral form of 4'-demethyl-epipodophyllotoxin-beta-D ethylidene glucoside (NSC 141540) VP 16-213.
    Cancer, 1975, Volume: 35, Issue:4

    Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Administration, Oral; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Female; Glucosides; Humans; Leukemia, Myeloid; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Mesothelioma; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Remission, Spontaneous; Urinary Bladder Neoplasms

1975